Data, methods, and tools developed by the TREAT-AD centers will be openly shared as they become available. Data and resource sharing is planned to start in early 2021. There are several websites and data portals that are relevant for TREAT-AD center research listed below.
Discover and download Alzheimer’s Disease data, analyses, and tools from the National Institute on Aging’s Alzheimer’s Disease Translational Research Program, including the Accelerating Medicines Partnership in AD (AMP-AD) consortium.
View a list of new AD targets nominated by the AD community, view the rationale for why they were nominated, and explore multi-omic evidence from studies of human brains.
Explore new mouse models for AD that are being generated by the MODEL-AD consortium.
Screening the Optimal Pharmaceutical for Alzheimer’s Disease (STOP-AD) is a program that offers preclinical screening of compounds through the MODEL-AD Preclinical Testing Core.